FindTrial
Sign In

Evaluation of titanium cranioplasty and polyetheretherketone cranioplasty: a multicenter, prospective, non-blind, randomized controlled study

Evaluation of titanium cranioplasty and custom-made polyetheretherketone cranioplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024625
Enrollment
Unknown
Registered
2019-07-19
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cranial defect

Interventions

Trial group:polyetheretherketone cranioplasty
control group:titanium cranioplasty

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Diagnosed with cranial defect; 2) Patients aged over 18 years; 3) The defect size is over 5 cm2; 4) Agree to participate in the clinic trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) With intracranial hematoma; 2) With intracranial infection; 3) With unhealed wounds.

Design outcomes

Primary

MeasureTime frame
post-operative complications;—

Secondary

MeasureTime frame
Time of surgery;Postoperative hospital stay;preoperative GCS score;postoperative GOS score;Cosmetic satisfaction outcomes;hospitalization expense;—

Countries

China

Contacts

Public ContactGuan Junwen

Department of Neurosurgery, West China Hospital of Sichuan University

guanjunwen_scu@163.com+86 13668267639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026